Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 211 for “"HSV-2"”.
-
Mathematics of HSV-2 Dynamics
… dynamics of herpes simplex virus type 2 (HSV-2), a sexually-transmitted disease of major public health significance. A deterministic model for the interaction of the virus with the immune system in the body of an infected individual (in vivo) is designed first of all. It is shown, using …
-
Cell Surface Protein Changes Associated with HSV-2 Transformation
… surface proteins of Herpes simplex virus type 2 (HSV-2) transformed hamster embryo fibroblasts (HaEF) were examined using a variety of radioactive isotope labeling techniques with subsequent analysis on sodium-dodecyl sulphate- polyacrylamide slab gels. As well, a number of biological parameters …
-
Identification of a 40KD Protein Increased by HSV-2 Infection
Herpes simplex virus (HSV) has been implicated in the etiology of human cancer, but its role in the transformation process is not well understood. A set of cellular polypeptides of 200KD, 90KD (a doublet U90 and L90) and 40KD (TBS:40) was previously detected by immunoprecipitation (i.p.) with …
-
The role of HSV-2 UL16 in nuclear egress of capsids
The herpes simplex virus (HSV) UL16 gene is conserved throughout the Herpesviridae and the herpes simplex virus type 1 (HSV-1) UL16 protein forms complex with another virus protein called UL21. Previous studies demonstrated that, unlike HSV-1, herpes simplex virus type 2 (HSV-2) UL21 was essential …
-
Investigation of excipients for the stabilization of HSV-2 vaccine candidate ACAM529
Herpes simplex virus type 2 (HSV-2) is a highly infectious pathogen that causes genital ulcerative disease and it affects millions of people worldwide. ACAM529 is a promising new live replication-deficient vaccine candidate against the virus. Vaccine stability during the upstream production …
-
An innate-like role of memory T cells in HSV-2 immunity
… worldwide. Herpes Simplex Virus type-2 (HSV-2) infection is one of the most prevalent sexually transmitted infections, yet no vaccine is currently available. An understanding of the cellular composition of tissue-resident immune cells at the primary site of infection is essential for …
-
Clinical Implications of HIV-1, HSV-2 Co-infection and Opportunities for Intervention
HSV-2 may have adverse consequences in HIV. I evaluated the impact of HSV-2 co-infection on (highly active antiretroviral therapy)-untreated HIV infection in a systematic review of observational studies (study 1) and a retrospective cohort (study 2). I further evaluated whether HSV reactivation …
-
Creating Live Attenuated HSV-2 Vaccine Candidate Strains Through Codon Pair Bias Deoptimization
Herpes simplex virus 2 (HSV-2) is the primary causative agent of genital herpes, a disease characterized by painful recurrent anogenital lesions, higher risks for HIV and other STD transmissions, and potential childbirth complications. Despite the large medical burden of HSV-2, no vaccines are …
-
Frequent Genital HSV-2 Shedding Among Women During Labor in Soweto, South Africa
… Despite high herpes simplex virus type 2 (HSV-2) incidence and prevalence in Africa, we are unaware of published neonatal herpes reports. To assess the potential for neonatal transmission we investigated the frequency of established risk factors including HSV acquisition in late pregnancy …
-
Development and characterization of a mouse model of HSV-2 infection during pregnancy
Problem: Primary HSV-2 infection during pregnancy is associated with adverse pregnancy outcomes. However the mechanisms underlying these outcomes remain largely unknown. In this study we developed and characterized a mouse model of primary HSV-2 infection during early pregnancy and examined its …
-
Effect of oral and gel tenofovir on genital HSV-2 shedding in immunocompetent women
… suggest that tenofovir also reduces the risk of HSV-2 acquisition. Whether oral or gel tenofovir may be useful in HSV disease management, or prevention of HSV-2 transmission, is unclear. Methods: We randomized immunocompetent women with symptomatic HSV-2 infection 2:2:1 to oral tenofovir/placebo …
-
The Role of HSV-2 Proteins ICP0 and Us3 in Counteracting Cellular Antiviral Defence
… on the role of two herpes simplex virus type 2 (HSV-2) proteins, ICP0 and Us3, in disrupting PML-NBs and counteracting cellular antiviral defence. En passant mutagenesis was used to create recombinant HSV-2 viruses lacking ICP0, Us3, or both ICP0 and Us3. Growth analysis of these recombinants …
-
The Effect of HSV-2 Infection on the Expression of Cellular Mitochondrial Aspartate Aminotransferase
… of rat embryo fibroblasts with a fragment of HSV-2. This group of polypeptides (200kDa, 90kDa (a doublet U90 and L90), 40kDa and 32kDa) were immunoprecipitated specifically from transformed cells by sera from tumour bearing rats, and from rats immunised with non-transformed HSV-2 infected …
-
Spatial stochastic models of HSV-2 lesion dynamics and their link with HIV-1 acquisition
Patients with Herpes Simplex Virus-2 (HSV-2) infection face a significantly higher risk of contracting HIV-1. This marked increase is thought to be due not only to herpetic lesions serving as an entry point for the HIV-1 virus, but also to the increase in CD4+ T cells in the human genital mucosa …
-
A Caulobacter crescentus microbicide prevents vaginal infection with HIV-1 and HSV-2 in preclinical models
… prevent infection with herpes simplex virus 2 (HSV-2). HSV-2 is a major co-morbidity for HIV-1 infection, contributing to a 2-4 fold increase in acquisition. Four recombinant C. crescentus provided significant protection from HSV-2 infection in vivo. Taken together this data suggests that a C. …
-
Developing Methods to Study Pathogenesis and Immune Response to HSV-2 in the Guinea Pig Model
In order to develop an effective vaccine for HSV-2 it is important to adequately understand the immune response in the proper animal model. Guinea pigs fully recapitulate human HSV-2 disease, but reagents and assays available for this animal are limited. Consequently, many reagents and assays used …
Page 1 of 11